Histogen Inc (HSTO) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access HSTO quarterly Cash Flow →
Tracking cash flow results across Histogen Inc to Dec 31 2018 helps illustrate how Dec 31 2022's cash generation has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
12 Months
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Operating Activities
Income-10.64
Depreciation & amortization0.14
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventory Write-down0.06
Research and Development in Process0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation0.50
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.28
Interest Costs Capitalized-
Increase Decrease In Contract With Customer Liability-0.02
Forgiveness Of Payroll Protection Program Loan-
Income taxes0.00
Gain (Loss) on Disposition of Stock in Subsidiary0.00
Increase (Decrease) in Accounts Receivable0.07
Increase (Decrease) in Accounts Payable-1.01
Increase (Decrease) in Accrued Liabilities-0.20
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.12
Other Working Capital0.22
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.21
Discontinued operations0.00
Net Cash flow from Operating Activities-9.68
Investing Activities
Capital Expenditures-0.22
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Cash Paid For Acquisition Related Costs-
Cash Paid For Acquisition Costs-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses and Interests in Affiliates0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.22
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock4.41
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-0.49
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-24.43
Payments Of Deferred Initial Public Offering Costs-
Proceeds From Issuance Of Promissory Notes And Warrants-
Proceeds From Convertible Promissory Notes-
Repayments Of Promissory Notes-
Repayments Of Capital Lease Obligations-0.01
Proceeds From Promissory Notes-
Payments On Promissory Notes-
Proceeds From Payroll Protection Program Loan-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations19.09
Conversion Of Stock Amount Converted4.76
Business Combination Consideration Transferred Equity Interests Issued And Issuable-
Noncash Or Part Noncash Acquisition Value Of Assets Acquired-
Noncash Or Part Noncash Acquisition Payables Assumed-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.32
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-9.90
Total Cash Flow-6.58
4 historic quarters locked

Sign in to unlock the full Histogen Inc cash flow history.

About Histogen Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-23-062115

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License